i started semaglutide at 52 Woman Says Weight-Loss Medication Stopped Sugar Cravings In a phase III trial,

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Mansbach C 2nd, Gorelick F

In the morning you use the C

Hyperglycemia typically disrupts the functional activities of eNOS and iNOS, leading to a diminished release of NO and consequently a reduced availability of NO, which adversely affects the angiogenic process

It is used to prevent and treat this condition in patients with kidney disease on dialysis

Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes at doses up to 2.0 mg) and Wegovy (approved for weight management at 2.4 mg)